Pronecrotic Mixed Lineage Kinase Domain-Like Protein Expression Is a Prognostic Biomarker in Patients With Early-Stage Resected Pancreatic Adenocarcinoma

BACKGROUND: Mixed lineage kinase domain-like protein (MLKL) is a necrosome component mediating programmed necrosis that may be an important determinant of cancer cell death. The goal of the current study was to evaluate the prognostic value of MLKL expression in patients with pancreatic adenocarcino...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer
Main Authors: Colbert, Lauren E., Fisher, Sarah B., Hardy, Claire W., Hall, William A., Saka, Burcu, Shelton, Joseph W., Petrova, Aleksandra V., Warren, Matthew D., Pantazides, Brooke G., Gandhi, Khanjan, Kowalski, Jeanne, Kooby, David A., El-Rayes, Bassel F., Staley, Charles A., Volkan Adsay, N., Curran, Walter J., Landry, Jerome C., Maithel, Shishir K., Yu, David S.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389890/
https://ncbi.nlm.nih.gov/pubmed/23720157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28144
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares